BNP Paribas Financial Markets’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-27,269
| Closed | -$657K | – | 3361 |
|
|
2023
Q1 | $657K | Buy |
27,269
+16,309
| +149% | +$393K | ﹤0.01% | 1989 |
|
|
2022
Q4 | $116K | Sell |
10,960
-10,557
| -49% | -$112K | ﹤0.01% | 2555 |
|
|
2022
Q3 | $96.8K | Buy |
21,517
+4,840
| +29% | +$21.8K | ﹤0.01% | 3080 |
|
|
2022
Q2 | $66.7K | Buy |
16,677
+11,165
| +203% | +$44.7K | ﹤0.01% | 2850 |
|
|
2022
Q1 | $40.3K | Sell |
5,512
-13,771
| -71% | -$101K | ﹤0.01% | 3028 |
|
|
2021
Q4 | $108K | Buy |
19,283
+6,191
| +47% | +$34.8K | ﹤0.01% | 2930 |
|
|
2021
Q3 | $83.8K | Buy |
13,092
+6,278
| +92% | +$40.2K | ﹤0.01% | 2746 |
|
|
2021
Q2 | $57.4K | Sell |
6,814
-35
| -0.5% | -$295 | ﹤0.01% | 2624 |
|
|
2021
Q1 | $71.9K | Sell |
6,849
-2,312
| -25% | -$24.3K | ﹤0.01% | 2931 |
|
|
2020
Q4 | $155K | Sell |
9,161
-1,994
| -18% | -$33.8K | ﹤0.01% | 2357 |
|
|
2020
Q3 | $143K | Buy |
11,155
+9,544
| +592% | +$122K | ﹤0.01% | 2316 |
|
|
2020
Q2 | $22.7K | Buy |
+1,611
| New | +$22.7K | ﹤0.01% | 2717 |
|